Literature DB >> 25157651

Sarcopenia: monitoring, molecular mechanisms, and physical intervention.

A Zembroń-Łacny1, W Dziubek, Ł Rogowski, E Skorupka, G Dąbrowska.   

Abstract

According to European Working Group on Sarcopenia in Older People (EWGSOP) sarcopenia includes both a loss of muscle strength and a decline in functional quality in addition to the loss of muscle protein mass. In order to develop strategies to prevent and treat sarcopenia, the risk factors and causes of sarcopenia must be identified. Age-related muscle loss is characterized by the contribution of multiple factors, and there is growing evidence for a prominent role of low-grade chronic inflammation in sarcopenia. The elderly who are less physically active are more likely to have lower skeletal muscle mass and strength and are at increased risk of developing sarcopenia. Resistance training added to aerobic exercise or high-intensity interval training promote numerous changes in skeletal muscle, many of which may help to prevent or reverse sarcopenia. In this review, we provided current information on definition and monitoring, molecular mechanisms, and physical intervention to counteract sarcopenia.

Entities:  

Mesh:

Year:  2014        PMID: 25157651

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  22 in total

1.  Assessing Health Span in Caenorhabditis elegans: Lessons From Short-Lived Mutants.

Authors:  Jarod A Rollins; Amber C Howard; Sarah K Dobbins; Elsie H Washburn; Aric N Rogers
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-04-01       Impact factor: 6.053

2.  One-year postoperative resource utilization in sarcopenic patients.

Authors:  Peter S Kirk; Jeffrey F Friedman; David C Cron; Michael N Terjimanian; Stewart C Wang; Darrell A Campbell; Michael J Englesbe; Nicole L Werner
Journal:  J Surg Res       Date:  2015-04-30       Impact factor: 2.192

Review 3.  Age-induced oxidative stress: how does it influence skeletal muscle quantity and quality?

Authors:  Cory W Baumann; Dongmin Kwak; Haiming M Liu; LaDora V Thompson
Journal:  J Appl Physiol (1985)       Date:  2016-05-19

Review 4.  Effect of Angiotensin-Converting Enzyme Inhibitors on Physical Function in Elderly Subjects: A Systematic Review and Meta-Analysis.

Authors:  Ling-shan Zhou; Ling-jie Xu; Xue-qing Wang; Yi-huan Huang; Qian Xiao
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

Review 5.  The anatomy of resting energy expenditure: body composition mechanisms.

Authors:  Steven B Heymsfield; Diana M Thomas; Anja Bosy-Westphal; Manfred J Müller
Journal:  Eur J Clin Nutr       Date:  2018-09-25       Impact factor: 4.016

6.  Muscle function decline and mitochondria changes in middle age precede sarcopenia in mice.

Authors:  Andrea Del Campo; Ignacio Contreras-Hernández; Mauricio Castro-Sepúlveda; Cristian A Campos; Reinaldo Figueroa; María Florencia Tevy; Verónica Eisner; Mariana Casas; Enrique Jaimovich
Journal:  Aging (Albany NY)       Date:  2018-01-04       Impact factor: 5.682

7.  Changes in DXA-derived lean mass and MRI-derived cross-sectional area of the thigh are modestly associated.

Authors:  Dallin Tavoian; Kwasi Ampomah; Shinichi Amano; Timothy D Law; Brian C Clark
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

8.  Sarcopenia as a predictor of hospitalization among older people: a systematic review and meta-analysis.

Authors:  Xiaoming Zhang; Wenwu Zhang; Conghua Wang; Wuyuan Tao; Qingli Dou; Yunzhi Yang
Journal:  BMC Geriatr       Date:  2018-08-22       Impact factor: 3.921

9.  Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy.

Authors:  Song Ee Park; In Gyu Hwang; Chang Hwan Choi; Hyun Kang; Beom Gyu Kim; Byung Kwan Park; Seong Jae Cha; Joung-Soon Jang; Jin Hwa Choi
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

10.  Resistance training might have improved insulin resistance by attenuating sarcopenia.

Authors:  Yildiray Topcu; Fatih Tufan; M Akif Karan
Journal:  Clin Interv Aging       Date:  2015-12-08       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.